rs143819820

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_018062.4(FANCL):​c.203G>C​(p.Arg68Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000508 in 1,609,506 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R68Q) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.00068 ( 0 hom., cov: 32)
Exomes š‘“: 0.00049 ( 1 hom. )

Consequence

FANCL
NM_018062.4 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:3

Conservation

PhyloP100: 1.90

Publications

15 publications found
Variant links:
Genes affected
FANCL (HGNC:20748): (FA complementation group L) This gene encodes a ubiquitin ligase that is a member of the Fanconi anemia complementation group (FANC). Members of this group are related by their assembly into a common nuclear protein complex rather than by sequence similarity. This gene encodes the protein for complementation group L that mediates monoubiquitination of FANCD2 as well as FANCI. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2018]
FANCL Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group L
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006917268).
BP6
Variant 2-58229827-C-G is Benign according to our data. Variant chr2-58229827-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 456243.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000677 (103/152238) while in subpopulation NFE AF = 0.000956 (65/68002). AF 95% confidence interval is 0.000769. There are 0 homozygotes in GnomAd4. There are 45 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCLNM_018062.4 linkc.203G>C p.Arg68Pro missense_variant Exon 3 of 14 ENST00000233741.9 NP_060532.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCLENST00000233741.9 linkc.203G>C p.Arg68Pro missense_variant Exon 3 of 14 1 NM_018062.4 ENSP00000233741.5 Q9NW38-1

Frequencies

GnomAD3 genomes
AF:
0.000677
AC:
103
AN:
152120
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00433
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000956
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000597
AC:
150
AN:
251158
AF XY:
0.000574
show subpopulations
Gnomad AFR exome
AF:
0.000247
Gnomad AMR exome
AF:
0.000434
Gnomad ASJ exome
AF:
0.00377
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000793
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.000491
AC:
715
AN:
1457268
Hom.:
1
Cov.:
28
AF XY:
0.000514
AC XY:
373
AN XY:
725318
show subpopulations
African (AFR)
AF:
0.0000300
AC:
1
AN:
33354
American (AMR)
AF:
0.000403
AC:
18
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00372
AC:
97
AN:
26078
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39566
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86152
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.00122
AC:
7
AN:
5736
European-Non Finnish (NFE)
AF:
0.000494
AC:
547
AN:
1108048
Other (OTH)
AF:
0.000631
AC:
38
AN:
60218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.432
Heterozygous variant carriers
0
35
69
104
138
173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000677
AC:
103
AN:
152238
Hom.:
0
Cov.:
32
AF XY:
0.000605
AC XY:
45
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41542
American (AMR)
AF:
0.000588
AC:
9
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00433
AC:
15
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000956
AC:
65
AN:
68002
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000804
Hom.:
1
Bravo
AF:
0.000578
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00116
AC:
10
ExAC
AF:
0.000470
AC:
57
EpiCase
AF:
0.00125
EpiControl
AF:
0.00142

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Fanconi anemia complementation group L Uncertain:2Benign:1
Sep 06, 2019
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fanconi anemia Uncertain:1Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2021
Sema4, Sema4
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:curation

- -

not specified Uncertain:1
Oct 08, 2019
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

FANCL-related disorder Benign:1
Jan 28, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
21
DANN
Benign
0.97
DEOGEN2
Benign
0.0062
T;T;.;T
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.29
FATHMM_MKL
Benign
0.58
D
LIST_S2
Benign
0.55
T;T;T;T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.0069
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.14
.;N;N;.
PhyloP100
1.9
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-0.40
N;N;N;.
REVEL
Benign
0.041
Sift
Benign
0.16
T;T;T;.
Sift4G
Benign
0.24
T;T;T;D
Polyphen
0.0070
B;B;B;.
Vest4
0.32
MVP
0.37
MPC
0.0088
ClinPred
0.0072
T
GERP RS
3.0
Varity_R
0.19
gMVP
0.62
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143819820; hg19: chr2-58456962; API